| 2020-11-11 | Sale | IDEAYA Biosciences, Inc. IDYA | 10 percent owner | 1.6M 5.7544% | $13.66 | $21.86M | +60.63% | |
| 2020-10-05 | Sale | Aprea Therapeutics, Inc. APRE | Former 10% holder | 175,000 0.7844% | $25.30 | $4.43M | -80.91% | |
| 2020-06-16 | Sale | Aprea Therapeutics, Inc. APRE | Former 10% holder | 140,000 0.6473% | $33.30 | $4.66M | -38.45% | |
| 2020-06-11 | Sale | Aprea Therapeutics, Inc. APRE | Former 10% holder | 245,000 1.1106% | $28.75 | $7.04M | -27.94% | |
| 2020-05-19 | Sale | Aprea Therapeutics, Inc. APRE | Former 10% holder | 255,000 1.3734% | $35.15 | $8.96M | -20.89% | |
| 2019-10-07 | Aprea Therapeutics, Inc. APRE | Former 10% holder | 333,333 1.2152% | $15.00 | $5M | +53.58% | ||
| 2019-06-21 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 500,000 0.9884% | $11.10 | $5.55M | -19.41% | ||
| 2019-05-28 | IDEAYA Biosciences, Inc. IDYA | 10 percent owner | 1.5M 16.0251% | $10.00 | $15M | -37.23% | ||
| 2019-03-18 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | 309,678 1.2266% | $24.25 | $7.51M | -13.3% | |
| 2019-01-22 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | 524,306 2.2591% | $21.88 | $11.47M | +9.87% | |
| 2018-07-20 | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | 230,000 0.8493% | $17.00 | $3.91M | +10.46% |